Ovarian Cancer: Key Abstracts From SGO 2023 Ovarian Cancer: Key Abstracts From SGO 2023

Key data in ovarian cancer presented at SGO 2023 include a reassessment of niraparib, olaparib as neoadjuvant therapy, and options in platinum-resistant disease, as reported by Dr Shannon Westin.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news